Cambridge Investment Research Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$96.9M Buy
521,793
+10,733
+2% +$1.99M 0.29% 52
2025
Q1
$107M Buy
511,060
+21,249
+4% +$4.45M 0.36% 45
2024
Q4
$87M Sell
489,811
-5,260
-1% -$935K 0.29% 57
2024
Q3
$97.8M Buy
495,071
+17,804
+4% +$3.52M 0.33% 47
2024
Q2
$81.9M Sell
477,267
-1,943
-0.4% -$333K 0.3% 51
2024
Q1
$87.3M Sell
479,210
-8,532
-2% -$1.55M 0.34% 47
2023
Q4
$75.6M Sell
487,742
-44,986
-8% -$6.97M 0.32% 52
2023
Q3
$79.4M Buy
532,728
+23,693
+5% +$3.53M 0.37% 48
2023
Q2
$68.6M Sell
509,035
-10,060
-2% -$1.36M 0.31% 50
2023
Q1
$82.7M Sell
519,095
-26,828
-5% -$4.28M 0.41% 40
2022
Q4
$88.2M Buy
545,923
+10,284
+2% +$1.66M 0.46% 36
2022
Q3
$71.9M Buy
535,639
+22,820
+4% +$3.06M 0.41% 42
2022
Q2
$78.5M Sell
512,819
-24,732
-5% -$3.79M 0.42% 39
2022
Q1
$87.1M Buy
537,551
+13,392
+3% +$2.17M 0.4% 37
2021
Q4
$71M Sell
524,159
-9,067
-2% -$1.23M 0.32% 55
2021
Q3
$57.5M Buy
533,226
+19,349
+4% +$2.09M 0.28% 60
2021
Q2
$57.9M Buy
513,877
+27,127
+6% +$3.06M 0.28% 67
2021
Q1
$52.7M Buy
486,750
+54,226
+13% +$5.87M 0.29% 64
2020
Q4
$46.3M Sell
432,524
-12,175
-3% -$1.3M 0.27% 67
2020
Q3
$39M Buy
444,699
+30,912
+7% +$2.71M 0.26% 71
2020
Q2
$40.6M Buy
413,787
+40,600
+11% +$3.99M 0.31% 61
2020
Q1
$28.4M Buy
373,187
+24,827
+7% +$1.89M 0.27% 73
2019
Q4
$30.8M Buy
348,360
+32,250
+10% +$2.86M 0.24% 84
2019
Q3
$23.9M Buy
316,110
+54,557
+21% +$4.13M 0.21% 99
2019
Q2
$19M Buy
261,553
+28,699
+12% +$2.09M 0.17% 123
2019
Q1
$18.8M Buy
232,854
+8,422
+4% +$679K 0.18% 118
2018
Q4
$20.7M Buy
224,432
+8,840
+4% +$815K 0.23% 94
2018
Q3
$20.4M Buy
215,592
+10,163
+5% +$961K 0.19% 115
2018
Q2
$19M Buy
205,429
+860
+0.4% +$79.7K 0.2% 112
2018
Q1
$19.4M Buy
204,569
+2,464
+1% +$233K 0.22% 100
2017
Q4
$19.5M Buy
202,105
+19,119
+10% +$1.85M 0.23% 93
2017
Q3
$16.3M Sell
182,986
-13,252
-7% -$1.18M 0.22% 92
2017
Q2
$14.2M Buy
196,238
+18,778
+11% +$1.36M 0.21% 94
2017
Q1
$11.6M Buy
177,460
+24,738
+16% +$1.61M 0.2% 101
2016
Q4
$9.56M Buy
152,722
+23,117
+18% +$1.45M 0.18% 114
2016
Q3
$8.17M Buy
129,605
+7,945
+7% +$501K 0.15% 121
2016
Q2
$7.53M Buy
121,660
+4,228
+4% +$262K 0.16% 124
2016
Q1
$6.71M Buy
117,432
+4,686
+4% +$268K 0.15% 123
2015
Q4
$6.68M Buy
112,746
+7,763
+7% +$460K 0.16% 123
2015
Q3
$5.71M Sell
104,983
-2,753
-3% -$150K 0.16% 130
2015
Q2
$7.24M Buy
107,736
+8,710
+9% +$585K 0.2% 106
2015
Q1
$5.8M Buy
99,026
+6,124
+7% +$359K 0.17% 127
2014
Q4
$6.08M Sell
92,902
-35
-0% -$2.29K 0.19% 112
2014
Q3
$5.37M Buy
92,937
+4,358
+5% +$252K 0.16% 135
2014
Q2
$5M Buy
88,579
+5,050
+6% +$285K 0.17% 118
2014
Q1
$4.29M Buy
83,529
+5,658
+7% +$291K 0.16% 125
2013
Q4
$4.11M Buy
77,871
+2,176
+3% +$115K 0.17% 124
2013
Q3
$3.39M Buy
75,695
+1,437
+2% +$64.3K 0.15% 143
2013
Q2
$3.07M Buy
+74,258
New +$3.07M 0.16% 134